Drug and Alcohol Dependence

Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors
pp. 1-10(10)
Authors: Darke S.; Ross J.; Lynskey M.; Teesson M.

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification
pp. 11-22(12)
Authors: Sobel B.-F.X.; Sigmon S.C.; Walsh S.L.; Johnson R.E.; Liebson I.A.; Nuwayser E.S.; Kerrigan J.H.; Bigelow G.E.

Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment
pp. 23-31(9)
Authors: Trafton J.A.; Oliva E.M.; Horst D.A.; Minkel J.D.; Humphreys K.

The external validity of results derived from ecstasy users recruited using purposive sampling strategies
pp. 33-40(8)
Authors: Topp L.; Barker B.; Degenhardt L.

Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes
pp. 41-50(10)
Authors: Sindelar J.L.; Jofre-Bonet M.; French M.T.; McLellan A.T.

Long-term voluntary d-amphetamine consumption and behavioral predictors for subsequent d-amphetamine addiction in rats
pp. 51-60(10)
Authors: Galli G.; Wolffgramm J.

Social network correlates of self-reported non-fatal overdose
pp. 61-67(7)
Authors: Latkin C.A.; Hua W.; Tobin K.

Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection
pp. 69-78(10)
Authors: Kuo I.; Sherman S.G.; Thomas D.L.; Strathdee S.A.

Impaired performance in a test of decision-making by opiate-dependent tobacco smokers
pp. 79-86(8)
Authors: Rotheram-Fuller E.; Shoptaw S.; Berman S.M.; London E.D.

Psychiatric disorders and attempted suicide among adolescents with substance use disorders
pp. 87-97(11)
Authors: Kelly T.M.; Cornelius J.R.; Clark D.B.

An evaluation of workshop training in motivational interviewing for addiction and mental health clinicians
pp. 99-106(8)
Authors: Baer J.S.; Rosengren D.B.; Dunn C.W.; Wells E.A.; Ogle R.L.; Hartzler B.